hello@uvisahealth.com
The common vaginal infections Bacterial Vaginosis (BV) and Candidiasis (Thrush/Svamp) can be treated with UVISA's device, which utilises light therapy to naturally restore the vaginal microbiome.
You might ask how light can be such an effective solution and, more importantly, how it can be fully safe for you to use. At UVISA, we understand the concerns that come with new treatment options. With safety as our top priority, we are committed to offering a safer and more effective alternative to the traditional and currently available treatments for vaginal infections. Our device uses light to target harmful bacteria and alleviate vaginal discomfort.
Light, a well-established antimicrobial agent, was commonly used in medical treatments long before antibiotics became widespread. Certain microbes are extremely sensitive to natural radiation, like sunlight, which humans are exposed to daily. The light in our device disrupts the microbial cell membranes, eliminating them without harming the human vaginal tissue.
As an EU MDA Class IIa medical device, UVISA’s solution has undergone extensive testing that has proven its ability to eradicate harmful microbes while preserving beneficial bacteria. Furthermore, our in-house ex vivo safety assessments on human vaginal tissues confirm the safe use of the light.
Current treatments for bacterial or yeast infections are largely pharmacological, relying on trial and error with antibiotics or antifungal medications. These options often come with side effects lasting 5 to 14 days. We believe women deserve better. That’s why we're introducing a small, insertable device designed to rebalance the microbiome - with no medications involved.
At UVISA, we believe women deserve better options. That’s why our device aims to empower women to take control of their health, providing a more efficient solution for treating vaginal infections while minimizing the side effects that come with traditional treatments.
of women (n=1200) are open to using the device, of which 53% women answered "Yes. Great idea!", and 38% said "Maybe. As long as it works and is safe."
of asked general practitioners, pharmacists and gynecologists would recommend (n=37) the product as long as there is clinical data supporting it.
addressable customers worldwide, referring to the amount of women who are chronic sufferers - highlighting the market potential.
We are happy to hear from you.
hello@uvisahealth.com